Brain insulin disruption: Antipsychotics' hidden metabolic toll in women
NCT ID NCT06251635
First seen Apr 02, 2026 · Last updated May 09, 2026 · Updated 2 times
Summary
This study looks at how antipsychotic drugs might disrupt insulin action in the brains of healthy young women, and how this changes across the menstrual cycle. Fifteen participants will receive olanzapine or a placebo, plus intranasal insulin, and undergo MRI scans. The goal is to understand why women on antipsychotics face higher rates of metabolic problems like diabetes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INSULIN RESISTANCE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre for Addiction and Mental Health (CAMH)
RECRUITINGToronto, Ontario, M6J 1H3, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.